GERON CORP Increase (Decrease) in Deposit Assets
GERON CORP (GERN) reported Increase (Decrease) in Deposit Assets of $1.86 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDepositOtherAssets · last filed 2026-03-02
- GERON CORP increase (decrease) in deposit assets for fiscal 2025 was $1.86M.
- GERON CORP increase (decrease) in deposit assets for fiscal 2024 was -$618.00K.
- GERON CORP increase (decrease) in deposit assets for fiscal 2023 was -$692.00K, a 216.50% decline from fiscal 2022.
- GERON CORP increase (decrease) in deposit assets for fiscal 2022 was $594.00K, a 84.40% decline from fiscal 2021.
| Period end | Increase (Decrease) in Deposit Assets 12 month |
|---|---|
| 2025-12-31 | $1.86M 10-K · filed 2026-03-02 |
| 2024-12-31 | -$618.00K 10-K · filed 2026-03-02 |
| 2023-12-31 | -$692.00K 10-K · filed 2026-03-02 |
| 2022-12-31 | $594.00K 10-K · filed 2025-02-27 |
| 2021-12-31 | $3.81M 10-K · filed 2024-02-28 |
| 2020-12-31 | $206.00K 10-K · filed 2023-03-16 |
| 2019-12-31 | $964.00K 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |